Abstract
AB132. P108. Intraoperative radiotherapy (IORT) followed by concurrent chemotherapy (CCRT) or stereotactic radiotherapy (SBRT) for locally advanced pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB132
(23 April 2018)
Abstract
AB131. P107. Prognostic value of preoperative nutritional and immunological factors in patients with pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB131
(23 April 2018)
Abstract
AB130. P106. Threedimensional visualization technology used in pancreatic surgery: a valuable tool for surgical trainees
Annals of Pancreatic Cancer
2018;
1:
AB130
(23 April 2018)
Abstract
AB129. P105. A comparative study of the totally onelayer and stratified pancreaticojejunostomy in pancreaticoduodenectomy
Annals of Pancreatic Cancer
2018;
1:
AB129
(23 April 2018)
Abstract
AB128. P104. Gemcitabine/ taxane adjuvant therapy with chemoradiation in resected pancreatic cancer: a novel strategy for improved survival?
Annals of Pancreatic Cancer
2018;
1:
AB128
(23 April 2018)
Abstract
AB127. P103. Evaluation of new stent for EUS-guided pancreatic duct drainage: longterm follow-up outcome
Annals of Pancreatic Cancer
2018;
1:
AB127
(23 April 2018)
Abstract
AB126. P102. Clinicopathological feature of early-stage pancreatic cancer—tumor size was less than 10 mm
Annals of Pancreatic Cancer
2018;
1:
AB126
(23 April 2018)
Abstract
AB125. P101. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis
Annals of Pancreatic Cancer
2018;
1:
AB125
(23 April 2018)
Abstract
AB124. P100. The prevalence and characteristics of pancreatic solid pseudopapillary tumor associate with malignance: a multicenter retrospective study in China
Annals of Pancreatic Cancer
2018;
1:
AB124
(23 April 2018)
Abstract
AB123. P099. Type 2 diabetes mellitus, a vital and independent risk factor for acute pancreatitis in patients with severe hypertriglyceridemia
Annals of Pancreatic Cancer
2018;
1:
AB123
(23 April 2018)
Abstract
AB122. P098. The effect of somatostatin analogues on postoperative outcomes following pancreatic surgery: a meta-analysis
Annals of Pancreatic Cancer
2018;
1:
AB122
(23 April 2018)
Abstract
AB121. P097. Retrospective comparison analysis between pathology and the fukuoka consensus in resected IPMN in a single center
Annals of Pancreatic Cancer
2018;
1:
AB121
(23 April 2018)
Abstract
AB120. P096. A new pancreatojejunostomy of ductto- mucosa combining “backto- back” cross horizontal mattress anastomosis reduce postoperative pancreatic fistula
Annals of Pancreatic Cancer
2018;
1:
AB120
(23 April 2018)
Abstract
AB119. P095. Organ preserving pancreatectomy for pancreatic benign or low-grade malignant tumor: a report of 66 cases in a single institution
Annals of Pancreatic Cancer
2018;
1:
AB119
(23 April 2018)
Abstract
AB118. P093. Impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB118
(23 April 2018)
Abstract
AB117. P092. Safety of intraoperative pancreatoscopy for the investigation of main pancreatic duct involvement and assessment of skip lesions in operated main duct (MD) involving IPMNs: a feasibility study
Annals of Pancreatic Cancer
2018;
1:
AB117
(23 April 2018)
Abstract
AB116. P090. Preliminary results with laparoscopic pancreatoduodenectomy: a comparative series with open procedure in a single center
Annals of Pancreatic Cancer
2018;
1:
AB116
(23 April 2018)
Abstract
AB115. P089. Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis
Annals of Pancreatic Cancer
2018;
1:
AB115
(23 April 2018)
Abstract
AB114. P088. Comparison between robotic assisted and the ‘gold standard’ open approach for left sided cystic tumors of the pancreas: results from a single center
Annals of Pancreatic Cancer
2018;
1:
AB114
(23 April 2018)
Abstract
AB113. P087. Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions
Annals of Pancreatic Cancer
2018;
1:
AB113
(23 April 2018)
Abstract
AB112. P086. MicroRNA miR- 141/200c inhibit proliferation, invasion and metastasis of human pancreatic cancer cells by targeting WIPF1-YAP/TAZ pathway
Annals of Pancreatic Cancer
2018;
1:
AB112
(23 April 2018)
Abstract
AB111. P085. The key factors related to the postoperative survival duration of patients with pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB111
(23 April 2018)
Abstract
AB110. P084. OGDHL inhibits human pancreatic ductal adenocarcinoma progression and is regulated by microRNA-214/TWIST1 negative feedback pathway
Annals of Pancreatic Cancer
2018;
1:
AB110
(23 April 2018)
Abstract
AB109. P083. Low expression of KLF9 in pancreatic cancer and its correlation with tumor differentiations
Annals of Pancreatic Cancer
2018;
1:
AB109
(23 April 2018)
Abstract
AB108. P082. Role of epigenetic modifying enzymes in the chemoresistance of pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB108
(23 April 2018)